MEDI vs XLV

Key Takeaways

• Harbor Health Care ETF (MEDI) is an actively managed fund targeting healthcare companies with a concentrated portfolio of approximately 37 holdings, while Health Care Select Sector SPDR Fund (XLV) passively tracks the healthcare sector of the S&P 500 Index with 63 holdings.
• MEDI carries a higher expense ratio of 0.80% compared to XLV’s 0.08%, reflecting its active strategy versus XLV’s low-cost passive replication approach.
• MEDI emphasizes global healthcare exposure with a focus on quality businesses meeting valuation criteria, whereas XLV provides broad U.S.-centric exposure to large-cap pharmaceuticals, equipment, providers, and biotechnology firms.
• Both ETFs offer healthcare sector exposure but differ in risk profiles: MEDI’s active management introduces potential for alpha generation alongside higher turnover and concentration risk, while XLV delivers diversified, index-aligned performance.
• In the current environment of innovation-driven healthcare growth and sector rotation, XLV provides cost-efficient broad exposure, while MEDI seeks differentiated returns through selective stock picking.

Introduction

Harbor Health Care ETF (MEDI) and Health Care Select Sector SPDR Fund (XLV) both target the healthcare sector, making them relevant for investors seeking exposure to pharmaceuticals, biotechnology, medical devices, and related services amid ongoing innovation and demographic tailwinds. They do not compete directly as identical products; instead, they represent alternative strategies within the same broad sector, with MEDI pursuing active thematic selection and XLV delivering passive, market-cap-weighted sector representation. This comparison highlights structural differences that influence suitability for varying investor objectives.

Harbor Health Care ETF (MEDI) Overview

Harbor Health Care ETF (MEDI) is an actively managed exchange-traded fund launched in November 2022 that seeks long-term capital growth by investing at least 80% of its assets in equity securities of companies principally engaged in the healthcare industry globally. The fund maintains a concentrated portfolio of roughly 37 holdings, with top positions including Eli Lilly & Co., Ascendis Pharma AS, Gilead Sciences Inc., Legend Biotech Corporation, and Rhythm Pharmaceuticals Inc. It features an expense ratio of 0.80% and exhibits higher turnover consistent with active management. Sector allocation is overwhelmingly healthcare at over 98%, with the remainder in cash. MEDI employs a fundamental, valuation-driven approach focused on quality businesses with differentiated products and technologies.

Health Care Select Sector SPDR Fund (XLV) Overview

Health Care Select Sector SPDR Fund (XLV) is a passively managed exchange-traded fund launched in December 1998 that seeks to track the performance of the Health Care Select Sector Index, representing the healthcare component of the S&P 500. The fund holds 63 securities and replicates the index through a low-turnover strategy, with top holdings typically led by large-cap names such as Eli Lilly & Co. and other major pharmaceutical and device companies. It carries a low expense ratio of 0.08% and maintains nearly 100% allocation to the healthcare sector. XLV provides broad, diversified exposure across pharmaceuticals, healthcare equipment and supplies, providers and services, biotechnology, and life sciences tools.

Industry and Thematic Backdrop

The healthcare sector continues to benefit from structural drivers including aging populations, advances in biotechnology and personalized medicine, and increasing demand for innovative therapies. Capital flows into the sector reflect ongoing interest in companies positioned for long-term growth in drug development and medical technology. Regulatory developments around drug pricing and patent expirations remain key variables, while macroeconomic factors such as interest rate expectations influence capital allocation between growth-oriented biotech and stable large-cap pharmaceutical names. Sector risks include policy uncertainty, clinical trial outcomes, and competitive pressures in high-growth areas.

Performance and Positioning Comparison

In recent market cycles, XLV has delivered steady, index-aligned returns driven by the performance of its large-cap holdings amid sector rotation favoring established healthcare leaders. MEDI’s active positioning has allowed for greater emphasis on select high-conviction names, potentially enhancing returns during periods of strong innovation momentum while introducing higher volatility due to concentration. Relative positioning shows XLV offering lower cost and broader diversification suitable for core allocations, whereas MEDI provides targeted exposure that may appeal during earnings cycles favoring specific therapeutic areas or when active managers identify undervalued opportunities within healthcare.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to uncover actionable insights across equities and funds.

Tickeron AI Verdict

Based on observable factors including structural strength, cost efficiency, diversification profile, and sector momentum, Tickeron’s AI would currently assign a higher probability of favorable positioning to Health Care Select Sector SPDR Fund (XLV) for investors prioritizing broad, low-cost exposure within the healthcare sector, while noting that Harbor Health Care ETF (MEDI) may suit those seeking active management and potential alpha in a concentrated healthcare portfolio.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations